DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study

Por Pedersen, Martin Bjerregård, Hamilton-Dutoit, Stephen Jacques, Bendix, Knud, Ketterling, Rhett P., Bedroske, Patrick P., Luoma, Ivy M., Sattler, Christopher A., Boddicker, Rebecca L., Bennani, N. Nora, Nørgaard, Peter, Møller, Michael Boe, Steiniche, Torben, d’Amore, Francesco, Feldman, Andrew L.
Publicado no Blood (2017)

C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Por Perez, Edith A., Jenkins, Robert B., Dueck, Amylou C., Wiktor, Anne E., Bedroske, Patrick P., Anderson, S. Keith, Ketterling, Rhett P., Sukov, William R., Kanehira, Kazunori, Chen, Beiyun, Geiger, Xochiquetzal J., Andorfer, Cathy A., McCullough, Ann E., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Kaufman, Peter A., Kutteh, Leila A., Gralow, Julie R., Harris, Lyndsay N., Ingle, James N., Lingle, Wilma L., Reinholz, Monica M.
Publicado em 2011